Literature DB >> 13679870

Differential expression of DOC-1 in microsatellite-unstable human colorectal cancer.

Ziqiang Yuan1, Tara Sotsky Kent, Thomas K Weber.   

Abstract

The precise genetic mechanism of malignant transformation in DNA mismatch repair deficient, microsatellite-unstable colorectal cancer (CRC) has yet to be elucidated. We employed cDNA microarray to identify patterns of gene expression among CRC cell lines and to compare directly lines with and without microsatellite instability. This study was undertaken to test the hypothesis that microsatellite-unstable CRC cell lines demonstrate specific patterns of gene expression that differ significantly from those observed among microsatellite-stable CRC. Multiple differential expression patterns were identified. Genes demonstrating differential expression included deleted-in-oral-cancer-1 (DOC-1), a highly conserved growth suppressor. DOC-1 expression correlated with microsatellite status, with significantly decreased expression in microsatellite-unstable cell lines and constitutive expression in microsatellite-stable cell lines. We also observed alterations in the biologic behavior of p12(DOC-1)-deficient cell lines, with increased S phase and decreased apoptosis compared to microsatellite-stable (DOC-1+) cell lines. Transfection of p12(DOC-1) into SW48, which lacks p12(DOC-1) expression, resulted in cell cycle and apoptosis profiles similar to other p12(DOC-1)+ cell lines. These results support the hypothesis that microsatellite-unstable CRC is characterized by novel patterns of gene expression different from those associated with microsatellite-stable CRC, and demonstrate that p12(DOC-1) has tumor suppressor potential in colon epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13679870     DOI: 10.1038/sj.onc.1206609

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties.

Authors:  Xavier Le Guezennec; Michiel Vermeulen; Arie B Brinkman; Wieteke A M Hoeijmakers; Adrian Cohen; Edwin Lasonder; Hendrik G Stunnenberg
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

2.  Human cyclin-dependent kinase 2-associated protein 1 (CDK2AP1) is dimeric in its disulfide-reduced state, with natively disordered N-terminal region.

Authors:  Asli Ertekin; James M Aramini; Paolo Rossi; Paul G Leonard; Haleema Janjua; Rong Xiao; Melissa Maglaqui; Hsiau-Wei Lee; James H Prestegard; Gaetano T Montelione
Journal:  J Biol Chem       Date:  2012-03-14       Impact factor: 5.157

3.  Microarray applications in cancer research.

Authors:  Il-Jin Kim; Hio Chung Kang; Jae-Gahb Park
Journal:  Cancer Res Treat       Date:  2004-08-31       Impact factor: 4.679

Review 4.  Double edge: CDK2AP1 in cell-cycle regulation and epigenetic regulation.

Authors:  D T W Wong; J J Kim; O Khalid; H H Sun; Y Kim
Journal:  J Dent Res       Date:  2011-08-24       Impact factor: 6.116

5.  p12(CDK2-AP1) inhibits breast cancer cell proliferation and in vivo tumor growth.

Authors:  Weibing Zhou; Xiaoyan Guan; Longyun Wang; Yuping Liao; Juan Huang
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-25       Impact factor: 4.553

Review 6.  Structure and function insights into the NuRD chromatin remodeling complex.

Authors:  Morgan P Torchy; Ali Hamiche; Bruno P Klaholz
Journal:  Cell Mol Life Sci       Date:  2015-03-22       Impact factor: 9.261

Review 7.  Familial colorectal cancer type X: genetic profiles and phenotypic features.

Authors:  Mev Dominguez-Valentin; Christina Therkildsen; Sabrina Da Silva; Mef Nilbert
Journal:  Mod Pathol       Date:  2014-04-18       Impact factor: 7.842

8.  The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer.

Authors:  Diana L Esposito; Federica Aru; Rossano Lattanzio; Annalisa Morgano; Michela Abbondanza; Reza Malekzadeh; Faraz Bishehsari; Rosa Valanzano; Antonio Russo; Mauro Piantelli; Antonio Moschetta; Lavinia Vittoria Lotti; Renato Mariani-Costantini
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

9.  Gene expression signatures for colorectal cancer microsatellite status and HNPCC.

Authors:  M Kruhøffer; J L Jensen; P Laiho; L Dyrskjøt; R Salovaara; D Arango; K Birkenkamp-Demtroder; F B Sørensen; L L Christensen; L Buhl; J-P Mecklin; H Järvinen; T Thykjaer; F P Wikman; F Bech-Knudsen; M Juhola; N N Nupponen; S Laurberg; C L Andersen; L A Aaltonen; T F Ørntoft
Journal:  Br J Cancer       Date:  2005-06-20       Impact factor: 7.640

10.  Colorectal cancers with microsatellite instability display mRNA expression signatures characteristic of increased immunogenicity.

Authors:  Ayan Banerjea; Shafi Ahmed; Rebecca E Hands; Fei Huang; Xia Han; Peter M Shaw; Roger Feakins; Stephen A Bustin; Sina Dorudi
Journal:  Mol Cancer       Date:  2004-08-06       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.